Further processing options
Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers
Saved in:
Journal Title: | Journal of Nuclear Medicine |
---|---|
Authors and Corporations: | , , , , , , , |
In: | Journal of Nuclear Medicine, 49, 2008, 6, p. 978-986 |
Type of Resource: | E-Article |
Language: | English |
published: |
Society of Nuclear Medicine
|
Subjects: |